Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified
| The first 150 words of the full text of this article appear below. |
EDITOR
Collinge et al recommend that tonsil biopsy be considered in all
those in whom new variant Creutzfeldt-Jakob disease is
suspected.1 Though the detection of protease resistant
prion protein in tonsillar tissue from a young person with a rapidly progressive dementia may have a high specificity for this diagnosis, there are no published data on sensitivity, specificity, or safety; the
procedure carries the risk of haemorrhage and infection as well as the
risks associated with anaesthesia. Some patients clinically suspected
of having new variant Creutzfeldt-Jakob disease, and therefore
potential candidates for tonsil biopsy, have subsequently recovered.2 Further information is obviously required, and we concur with the recommendation of a recent WHO consultation that
this should come from postmortem studies.3
Brain biopsy has been carried out in 9 of the 27 cases of new variant
Creutzfeldt-Jakob disease in the United Kingdom. This procedure has
risks but, in contrast to tonsillar biopsy, enables